Cardiovascular benefits of exogenous insulin

Journal of Clinical Endocrinology and Metabolism

Volumn 97, Issue 9, 2012, Pages 3079-3091

  Chaudhuri, Ajay ^a   Dandona, Paresh ^b,d   Fonseca, Vivian ^c  

^a MILLARD FILLMORE HOSPITAL   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

^c TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^d STATE UNIVERSITY OF NEW YORK   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; POTASSIUM;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; ANTIINFLAMMATORY ACTIVITY; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR EFFECT; CORONARY ARTERY BLOOD FLOW; DRUG MECHANISM; EXPERIMENTAL MODEL; GLUCOSE INTAKE; GLYCEMIC CONTROL; HEART FAILURE; HEART PROTECTION; HEART SURGERY; HUMAN; HYPOGLYCEMIA; NEUROPROTECTION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OUTCOME ASSESSMENT; PERIPHERAL CIRCULATION; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SIGNAL TRANSDUCTION; STROKE; SURGICAL INFECTION; SYSTEMATIC REVIEW; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE; VASODILATATION;

ANIMALS; ATHEROSCLEROSIS; BLOOD CIRCULATION; BLOOD GLUCOSE; CARDIAC SURGICAL PROCEDURES; CARDIOVASCULAR DISEASES; CASE MANAGEMENT; DIABETES MELLITUS, TYPE 2; ENDOTHELIUM, VASCULAR; GLUCOSE; HEART; HEART FUNCTION TESTS; HUMANS; HYPOGLYCEMIC AGENTS; INFLAMMATION; INSULIN; INTENSIVE CARE; MUSCLE, SMOOTH, VASCULAR; MYOCARDIAL INFARCTION; PLATELET AGGREGATION INHIBITORS; SIGNAL TRANSDUCTION; VASODILATION;

EID: 84866162508     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2012-1112     Document Type: Review

References (108)

1. Wysham CH 2010 New perspectives in type 2 diabetes, cardiovascular risk, and treatment goals. Postgrad Med 122:52-60
2. Kahn CR, White MF 1988 The insulin receptor and the molecular mechanism of insulin action. J Clin Invest 82:1151-1156
3. Steinberg HO, Brechtel G, Johnson A, Fineberg N, Baron AD 1994 Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent. A novel action of insulin to increase nitric oxide release. J Clin Invest 94:1172-1179
4. Scherrer U, Randin D, Vollenweider P, Vollenweider L, Nicod P 1994 Nitric oxide release accounts for insulin's vascular effects in humans. J Clin Invest 94:2511-2515 (Pubitemid 24379629)
5. Dandona P, Chaudhuri A, Ghanim H, Mohanty P 2009 Insulin as an anti-inflammatory and antiatherogenic modulator. J Am Coll Cardiol 53(5 Suppl):S14-S20
6. Dandona P, Mohanty P, Chaudhuri A, Garg R, Aljada A 2005 Insulin infusion in acute illness. J Clin Invest 115:2069-2072 (Pubitemid 41134145)
7. Dobrin JS, Lebeche D 2010 Diabetic cardiomyopathy: signaling defects and therapeutic approaches. Expert Rev Cardiovasc Ther 8:373-391
8. Steinberg HO, Chaker H, Leaming R, Johnson A, Brechtel G, Baron AD 1996 Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance. J Clin Invest 97:2601-2610
9. Grover A, Padginton C, Wilson MF, Sung BH, Izzo Jr JL, Dandona P 1995 Insulin attenuates norepinephrine-induced vasoconstriction: an ultrasonographic study. Hypertension 25:779-784
10. Baron AD, Steinberg HO, Chaker H, Leaming R, Johnson A, Brechtel G 1995 Insulin-mediated skeletal muscle vasodilation contributes to both insulin sensitivity and responsiveness in lean humans. J Clin Invest 96:786-792
11. Coggins M, Lindner J, Rattigan S, Jahn L, Fasy E, Kaul S, Barrett E 2001 Physiologic hyperinsulinemia enhances human skeletal muscle perfusion by capillary recruitment. Diabetes 50:2682-2690 (Pubitemid 33733118)
12. Vincent MA, Clerk LH, Rattigan S, Clark MG, Barrett EJ 2005 Active role for the vasculature in the delivery of insulin to skeletal muscle. Clin Exp Pharmacol Physiol 32:302-307 (Pubitemid 40586066)
13. Potenza MA, Addabbo F, Montagnani M 2009 Vascular actions of insulins with implications for endothelial dysfunction. Am J Physiol Endocrinol Metab 297:E568-E577
14. Bertrand L, Horman S, Beauloye C, Vanoverschelde JL 2008 Insulin signaling in the heart. Cardiovasc Res 79:238-248
15. Muniyappa R, Montagnani M, Koh KK, Quon MJ 2007 Cardiovascular actions of insulin. Endocr Rev 28:463-491 (Pubitemid 47236334)
16. Vincent MA, Clerk LH, Lindner JR, Price WJ, Jahn LA, Leong-Poi H, Barrett EJ 2006 Mixed meal and light exercise each recruit muscle capillaries in healthy humans. Am J Physiol Endocrinol Metab 290:E1191-E1197 (Pubitemid 43847903)
17. Vollenweider P, Tappy L, Randin D, Schneiter P, Jéquier E, Nicod P, Scherrer U 1993 Differential effects of hyperinsulinemia and carbohydrate metabolism on sympathetic nerve activity and muscle blood flow in humans. J Clin Invest 92:147-154 (Pubitemid 23208990)
18. Wei K, Kaul S 2004 The coronary microcirculation in health and disease. Cardiol Clin 22:221-231 (Pubitemid 38680768)
19. Baron AD 1994 Hemodynamic actions of insulin. Am J Physiol 267:E187-E202
20. Sundell J, Nuutila P, Laine H, Luotolahti M, Kalliokoski K, Raitakari O, Knuuti J 2002 Dose-dependent vasodilating effects of insulin on adenosine-stimulated myocardial blood flow. Diabetes 51:1125-1130 (Pubitemid 34438359)
21. Srinivasan M, Herrero P, McGill JB, Bennik J, Heere B, Lesniak D, Davila-Roman VG, Gropler RJ 2005 The effects of plasma insulin and glucose on myocardial blood flow in patients with type 1 diabetes mellitus. J Am Coll Cardiol 46:42-48 (Pubitemid 40905127)
22. Iozzo P, Chareonthaitawee P, Di Terlizzi M, Betteridge DJ, Ferrannini E, Camici PG 2002 Regional myocardial blood flow and glucose utilization during fasting and physiological hyperinsulinemia in humans. Am J Physiol Endocrinol Metab 282:E1163-E1171 (Pubitemid 34654732)
23. Trovati M, Anfossi G, Massucco P, Mattiello L, Costamagna C, Piretto V, Mularoni E, Cavalot F, Bosia A, Ghigo D 1997 Insulin stimulates nitric oxide synthesis in human platelets and, through nitric oxide, increases platelet concentrations of both guanosine-3′, 5′-cyclic monophosphate and adenosine-3′, 5′-cyclic monophosphate. Diabetes 46:742-749 (Pubitemid 27188249)
24. Anfossi G, Russo I, Trovati M 2006 Platelet resistance to the antiaggregating agents in the insulin resistant states. Curr Diabetes Rev 2:409-430 (Pubitemid 44734228)
25. Worthley MI, Holmes AS, Willoughby SR, Kucia AM, Heresztyn T, Stewart S, Chirkov YY, Zeitz CJ, Horowitz JD 2007 The deleterious effects of hyperglycemia on platelet function in diabetic patients with acute coronary syndromes: mediation by superoxide production, resolution with intensive insulin administration. J Am Coll Cardiol 49:304-310 (Pubitemid 46097375)
26. Zeng G, Quon MJ 1996 Insulin-stimulated production of nitric oxide is inhibited by wortmannin: direct measurement in vascular endothelial cells. J Clin Invest 98:894-898 (Pubitemid 26293305)
27. Aljada A, Dandona P 2000 Effect of insulin on human aortic endothelial nitric oxide synthase. Metabolism 49:147-150 (Pubitemid 30090874)
28. Moncada S, Higgs A 1993 The L-arginine-nitric oxide pathway. N Engl J Med 329:2002-2012 (Pubitemid 24015045)
29. Takahashi S, Mendelsohn ME 2003 Synergistic activation of endothelial nitric oxide synthase (eNOS) by HSP90 and Akt: calciumindependent eNOS activation involves formation of an HSP90-Akt-CaM-bound eNOS complex. J Biol Chem 278:30821-30827 (Pubitemid 36994590)
30. Federici M, Pandolfi A, De Filippis EA, Pellegrini G, Menghini R, Lauro D, Cardellini M, Romano M, Sesti G, Lauro R, Consoli A 2004 G972R IRS-1 variant impairs insulin regulation of endothelial nitric oxide synthase in cultured human endothelial cells. Circulation 109:399-405 (Pubitemid 38133910)
31. Begum N, Ragolia L, Rienzie J, McCarthy M, Duddy N 1998 Regulation of mitogen-activated protein kinase phosphatase-1 induction by insulin in vascular smooth muscle cells. Evaluation of the role of the nitric oxide signaling pathway and potential defects in hypertension. J Biol Chem 273:25164-25170 (Pubitemid 28443276)
32. Trovati M, Massucco P, Mattiello L, Cavalot F, Mularoni E, Hahn A, Anfossi G 1995 Insulin increases cyclic nucleotide content in human vascular smooth muscle cells: a mechanism potentially involved in insulin-induced modulation of vascular tone. Diabetologia 38:936-941
33. Etienne-Manneville S, Hall A 2002 Rho GTPases in cell biology. Nature 420:629-635 (Pubitemid 36764489)
34. Berweck S, Thieme H, Lepple-Wienhues A, Helbig H, Wiederholt M1993 Insulin-induced hyperpolarization in retinal capillary pericytes. Invest Ophthalmol Vis Sci 34:3402-3407 (Pubitemid 23346673)
35. Tirupattur PR, Ram JL, Standley PR, Sowers JR 1993 Regulation of Na+,K(+)-ATPase gene expression by insulin in vascular smooth muscle cells. Am J Hypertens 6:626-629 (Pubitemid 23248830)
36. Wiecha J, Reineker K, Reitmayer M, Voisard R, Hannekum A, Mattfeldt T, Waltenberger J, Hombach V 1998 Modulation of Ca2+-activated K+ channels in human vascular cells by insulin and basic fibroblast growth factor. Growth Horm IGF Res 8:175-181 (Pubitemid 29119482)
37. Kim YC, Zemel MB 1993 Insulin increases vascular smooth muscle recovery from intracellular calcium loads. Hypertension 22:74-77 (Pubitemid 23187386)
38. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH 1997 Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 336:973-979 (Pubitemid 27152782)
39. Ross R 1999 Atherosclerosis-an inflammatory disease. N Engl J Med 340:115-126
40. Dandona, P, Chaudhuri A 2006 Anti-inflammatory and antiatherogenic effects of insulin. Insulin 1(Suppl 1):S11-S17 (Pubitemid 44490356)
41. Aljada A, Ghanim H, Saadeh R, Dandona P 2001 Insulin inhibits NF-κB and MCP-1 expression in human aortic endothelial cells. J Clin Endocrinol Metab 86:450-453 (Pubitemid 32109834)
42. Dandona P, Aljada A, Mohanty P, Ghanim H, Hamouda W, Assian E, Ahmad S 2001 Insulin inhibits intranuclear nuclear factor κB and stimulates IκB in mononuclear cells in obese subjects: evidence for an anti-inflammatory effect? J Clin Endocrinol Metab 86:3257-3265 (Pubitemid 32674120)
43. Barnes PJ, Karin M 1997 Nuclear factor-κB: a pivotal transcription factor in chronic inflammatory disease. N Engl J Med 336:1066-1071 (Pubitemid 27163860)
44. Aljada A, Saadeh R, Assian E, Ghanim H, Dandona P 2000 Insulin inhibits the expression of intracellular adhesion molecule-1 by human aortic endothelial cells through stimulation of nitric oxide. J Clin Endocrinol Metab 85:2572-2575 (Pubitemid 32269217)
45. Jeschke MG, Einspanier R, Klein D, Jauch KW 2002 Insulin attenuates the systemic inflammatory response to thermal trauma. Mol Med 8:443-450 (Pubitemid 36337488)
46. Dandona P, Aljada A, Mohanty P, Ghanim H, Bandyopadhyay A, Chaudhuri A 2003 Insulin suppresses plasma concentration of vascular endothelial growth factor and matrix metalloproteinase-9. Diabetes Care 26:3310-3314 (Pubitemid 37466892)
47. Ghanim H, Korzeniewski K, Sia CL, Abuaysheh S, Lohano T, Chaudhuri A, Dandona P 2010 Suppressive effect of insulin infusion on chemokines and chemokine receptors. Diabetes Care 33:1103-1108
48. Aljada A, Ghanim H, Mohanty P, Kapur N, Dandona P 2002 Insulin inhibits the pro-inflammatory transcription factor early growth response gene-1 (Egr)-1 expression in mononuclear cells (MNC) and reduces plasma tissue factor (TF) and plasminogen activator inhibitor-1 (PAI-1) concentrations. J Clin Endocrinol Metab 87:1419-1422 (Pubitemid 36121118)
49. Li H, Sun B 2007 Toll-like receptor 4 in atherosclerosis. J Cell Mol Med 11:88-95 (Pubitemid 46439627)
50. Ghanim H, Mohanty P, Deopurkar R, Sia CL, Korzeniewski K, Abuaysheh S, Chaudhuri A, Dandona P 2008 Acute modulation of toll-like receptors by insulin. Diabetes Care 31:1827-1831
51. Dandona P, Ghanim H, Bandyopadhyay A, Korzeniewski K, Ling Sia C, Dhindsa S, Chaudhuri A 2010 Insulin suppresses endotoxin induced oxidative, nitrosative and inflammatory stress in humans. Diabetes Care 33:2416-2423
52. Pradhan AD, Everett BM, Cook NR, Rifai N, Ridker PM 2009 Effects of initiating insulin and metformin on glycemic control and inflammatory biomarkers among patients with type 2 diabetes. JAMA 302:1186-1194
53. Nathan DM, Lachin J, Cleary P, Orchard T, Brillon DJ, Backlund JY, O'Leary DH, Genuth S 2003 Intensive diabetes therapy and carotid intima-media thickness in type 1 diabetes mellitus. N Engl J Med 348:2294-2303 (Pubitemid 36638103)
54. Shamir R, Shehadeh N, Rosenblat M, Eshach-Adiv O, Coleman R, Kaplan M, Hamoud S, Lischinsky S, Hayek T 2003 Oral insulin supplementation attenuates atherosclerosis progression in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 23:104-110 (Pubitemid 36091633)
55. Rask-Madsen C, Li Q, Freund B, Feather D, Abramov R, Wu IH, Chen K, Yamamoto-Hiraoka J, Goldenbogen J, Sotiropoulos KB, Clermont A, Geraldes P, Dall'Osso C, Wagers AJ, Huang PL, Rekhter M, Scalia R, Kahn CR, King GL 2010 Loss of insulin signaling in vascular endothelial cells accelerates atherosclerosis in apolipoprotein E null mice. Cell Metab 11:379-389
56. Kubota T, Kubota N, Moroi M,Terauchi Y, Kobayashi T, Kamata K, Suzuki R, Tobe K, Namiki A, Aizawa S, Nagai R, Kadowaki T, Yamaguchi T 2003 Lack of insulin receptor substrate-2 causes progressive neointima formation in response to vessel injury. Circulation 107:3073-3080 (Pubitemid 36758982)
57. Galkina EV, Butcher M, Keller SR, Goff M, Bruce A, Pei H, Sarembock IJ, Sanders JM, Nagelin MH, Srinivasan S, Kulkarni RN, Hedrick CC, Lattanzio FA, Dobrian AD, Nadler JL, Ley K 2012 Accelerated atherosclerosis in apoE-/- mice heterozygous for the insulin receptor and the insulin receptor substrate-1. Arterioscler Thromb Vasc Biol 32:247-256
58. Breen DM, Chan KK, Dhaliwall JK, Ward MR, Al Koudsi N, Lam L, De Souza M, Ghanim H, Dandona P, Stewart DJ, Bendeck MP, Giacca A 2009 Insulin increases reendothelialization and inhibits cell migration and neointimal growth after arterial injury. Arterioscler Thromb Vasc Biol 29:1060-1066
59. Mohanty P, Hamouda W, Garg R, Aljada A, Ghanim H, Dandona P 2000 Glucose challenge stimulates reactive oxygen species (ROS) generation by leucocytes. J Clin Endocrinol Metab 85:2970-2973 (Pubitemid 32269184)
60. Dhindsa S, Tripathy D, Mohanty P, Ghanim H, Syed T, Aljada A, Dandona P 2004 Differential effects of glucose and alcohol on reactive oxygen species generation and intranuclear nuclear factor-κB in mononuclear cells. Metabolism 53:330-334 (Pubitemid 38684693)
61. Aljada A, Ghanim H, Mohanty P, Syed T, Bandyopadhyay A, Dandona P 2004 Glucose intake induces an increase in activator protein 1 and early growth response 1 binding activities, in the expression of tissue factor and matrix metalloproteinase in mononuclear cells, and in plasma tissue factor and matrix metalloproteinase concentrations. Am J Clin Nutr 80:51-57 (Pubitemid 41115554)
62. Esposito K, Nappo F, Marfella R, Giugliano G, Giugliano F, Ciotola M, Quagliaro L, Ceriello A, Giugliano D 2002 Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation 106:2067-2072 (Pubitemid 35192812)
63. Monnier L, Mas E, Ginet C, Michel F, Villon L, Cristol JP, Colette C 2006 Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA 295:1681-1687
64. Dandona P 2002 Endothelium, inflammation, and diabetes. Curr Diab Rep 2:311-315
65. Malouf JF, Kanagala R, Al Atawi FO, Rosales AG, Davison DE, Murali NS, Tsang TS, Chandrasekaran K, Ammash NM, Friedman PA, Somers VK 2005 High sensitivity C-reactive protein: a novel predictor for recurrence of atrial fibrillation after successful cardioversion. J Am Coll Cardiol 46:1284-1287 (Pubitemid 41615550)
66. Ishida K, Kimura F, Imamaki M, Ishida A, Shimura H, Kohno H, Sakurai M, Miyazaki M 2006 Relation of inflammatory cytokines to atrial fibrillation after off-pump coronary artery bypass grafting. Eur J Cardiothorac Surg 29:501-505
67. Umpierrez GE, Isaacs SD, Bazargan N, You X, Thaler LM, Kitabchi AE 2002 Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab 87:978-982 (Pubitemid 36121050)
68. Wahab NN, Cowden EA, Pearce NJ, Gardner MJ, Merry H, Cox JL 2002 Is blood glucose an independent predictor of mortality in acute myocardial infarction in the thrombolytic era? J Am Coll Cardiol 40:1748-1754 (Pubitemid 35341952)
69. Capes SE, Hunt D, Malmberg K, Gerstein HC 2000 Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet 355:773-778 (Pubitemid 30128815)
70. Capes SE, Hunt D, Malmberg K, Pathak P, Gerstein HC 2001 Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview. Stroke 32:2426-2432 (Pubitemid 32954818)
71. Mehta SR, Yusuf S, Díaz R, Zhu J, Pais P, Xavier D, Paolasso E, Ahmed R, Xie C, Kazmi K, Tai J, Orlandini A, Pogue J, Liu L 2005 Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction. JAMA 293:437-446
72. Iwakura K, Ito H, Ikushima M, Kawano S, Okamura A, Asano K, Kuroda T, Tanaka K, Masuyama T, Hori M, Fujii K 2003 Association between hyperglycemia and the no-reflow phenomenon in patients with acute myocardial infarction. J Am Coll Cardiol 41:1-7 (Pubitemid 36044395)
73. Timmer JR, Ottervanger JP, de Boer MJ, Dambrink JH, Hoorntje JC, Gosselink AT, Suryapranata H, Zijlstra F, van't Hof AW 2005 Hyperglycemia is an important predictor of impaired coronary flow before reperfusion therapy in ST-segment elevation myocardial infarction. J Am Coll Cardiol 45:999-1002 (Pubitemid 40432429)
74. Corpus RA, George PB, House JA, Dixon SR, Ajluni SC, Devlin WH, Timmis GC, Balasubramaniam M, O'Neill WW 2004 Optimal glycemic control is associated with a lower rate of target vessel revascularization in treated type II diabetic patients undergoing elective percutaneous coronary intervention. J Am Coll Cardiol 43:8-14 (Pubitemid 38045906)
75. Jonassen AK, Brar BK, Mjøs OD, Sack MN, Latchman DS, Yellon DM 2000 Insulin administered at reoxygenation exerts a cardioprotective effect in myocytes by a possible anti-apoptotic mechanism. J Mol Cell Cardiol 32:757-764 (Pubitemid 30658913)
76. Tune JD, Mallet RT, Downey HF 1998 Insulin improves contractile function during moderate ischemia in canine left ventricle. Am J Physiol 274:H1574-H1581
77. Zhang HX, Zang YM, Huo JH, Liang SJ, Zhang HF, Wang YM, Fan Q, Guo WY, Wang HC, Gao F 2006 Physiologically tolerable insulin reduces myocardial injury and improves cardiac functional recovery in myocardial ischemic/reperfused dogs. J Cardiovasc Pharmacol 48:306-313 (Pubitemid 46066836)
78. Gao F, Gao E, Yue TL, Ohlstein EH, Lopez BL, Christopher TA, Ma XL 2002 Nitric oxide mediates the antiapoptotic effect of insulin in myocardial ischemia-reperfusion: the roles of PI3-kinase, AkT, and endothelial nitric oxide synthase phosphorylation. Circulation 105:1497-1502 (Pubitemid 34263284)
79. Su H, Sun X, Ma H, Zhang HF, Yu QJ, Huang C, Wang XM, Luan RH, Jia GL, Wang HC, Gao F 2007 Acute hyperglycemia exacerbates myocardial ischemia/reperfusion injury and blunts cardioprotective effect of GIK. Am J Physiol Endocrinol Metab 293:E629-E635 (Pubitemid 47358973)
80. Marfella R, Di Filippo C, Portoghese M, Ferraraccio F, Rizzo MR, Siniscalchi M, Musacchio E, D'Amico M, Rossi F, Paolisso G 2009 Tight glycemic control reduces heart inflammation and remodeling during acute myocardial infarction in hyperglycemic patients. JAm Coll Cardiol 53:1425-1436
81. Kosiborod M, Inzucchi SE, Krumholz HM, Masoudi FA, Goyal A, Xiao L, Jones PG, Fiske S, Spertus JA 2009 Glucose normalization and outcomes in patients with acute myocardial infarction. Arch Intern Med 169:438-446
82. Malmberg K, Rydén L, Efendic S, Herlitz J, Nicol P, Waldenström A, Wedel H, Welin L 1995 Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI Study): effects on mortality at 1 year. J Am Coll Cardiol 26:57-65
83. Malmberg K, Rydén L, Wedel H, Birkeland K, Bootsma A, Dickstein K, Efendic S, Fisher M, Hamsten A, Herlitz J, Hildebrandt P, MacLeod K, Laakso M, Torp-Pedersen C, Waldenström A 2005 DIGAMI 2 Investigators. Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity. Eur Heart J 26:650-661 (Pubitemid 40516876)
84. Cheung NW, Wong VW, McLean M 2006 The hyperglycemia: intensive insulin infusion in infarction (HI-5) study: a randomized controlled trial of insulin infusion therapy for myocardial infarction. Diabetes Care 29:765-770 (Pubitemid 44115291)
85. Chaudhuri A, Janicke D, Wilson MF, Tripathy D, Garg R, Bandyopadhyay A, Calieri J, Hoffmeyer D, Syed T, Ghanim H, Aljada A, Dandona P 2004 Anti-inflammatory and profibrinolytic effect of insulin in acute ST-segment-elevation myocardial infarction. Circulation 109:849-854 (Pubitemid 38252736)
86. Chaudhuri A, Janicke D, Wilson M, Ghanim H, Wilding GE, Aljada A, Dandona P 2007 Effect of modified glucose-insulin-potassium on free fatty acids, matrix metalloproteinase, and myoglobin in ST-elevation myocardial infarction. Am J Cardiol 100:1614-1618 (Pubitemid 350122327)
87. Fath-Ordoubadi F, Beatt KJ 1997 Glucose-insulin-potassium therapy for treatment of acute myocardial infarction. An overview of randomized placebo-controlled trials. Circulation 96:1152-1156 (Pubitemid 27344217)
88. Goyal A, Mehta SR, Díaz R, Gerstein HC, Afzal R, Xavier D, Liu L, Pais P, Yusuf S 2009 Differential clinical outcomes associated with hypoglycaemia and hyperglycemia in acute myocardial infarction. Circulation 120:2429-2437
89. Chaudhuri A, Nesto R, Dandona P 2008 Glucose-insulin-potassium therapy in patients with STEMI. JAMA 299:2386-2387; author reply 2387-2388
90. Díaz R, Goyal A, Mehta SR, Afzal R, Xavier D, Pais P, Chrolavicius S, Zhu J, Kazmi K, Liu L, Budaj A, Zubaid M, Avezum A, Ruda M, Yusuf S 2007 Glucose-insulin-potassium therapy in patients with ST-segment elevation myocardial infarction. JAMA 298:2399-2405 (Pubitemid 350190781)
91. Lazar HL, Chipkin SR, Fitzgerald CA, Bao Y, Cabral H, Apstein CS 2004 Tight glycemic control in diabetes coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events. Circulation 109:1497-1502 (Pubitemid 38420177)
92. Quinn DW, Pagano D, Bonser RS, Rooney SJ, Graham TR, Wilson IC, Keogh BE, Townend JN, Lewis ME, Nightingale P 2006 Improved myocardial protection during coronary artery surgery with glucose-insulin-potassium: a randomized controlled trial. J Thorac Cardiovasc Surg 131:34-42
93. Visser L, Zuurbier CJ, Hoek FJ, Opmeer BC, de Jonge E, de Mol BA, van Wezel HB 2005 Glucose, insulin and potassium applied as perioperative hyperinsulinaemic normoglycaemic clamp: effects on inflammatory response during coronary artery surgery. Br J Anaesth 95:448-457 (Pubitemid 41418737)
94. van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R 2001 Intensive insulin therapy in critically ill patients.NEngl JMed 345:1359-1367
95. Frisch A, Chandra P, Smiley D, Peng L, Rizzo M, Gatcliffe C, Hudson M, Mendoza J, Johnson R, Lin E, Umpierrez GE 2010 Prevalence and clinical outcome of hyperglycemia in the perioperative period in noncardiac surgery. Diabetes Care 33:1783-1788
96. Subramaniam B, Panzica PJ, Novack V, Mahmood F, Matyal R, Mitchell JD, Sundar E, Bose R, Pomposelli F, Kersten JR, Talmor DS 2009 Continuous perioperative insulin infusion decreases major cardiovascular events in patients undergoing vascular surgery. Anesthesiology 110:970-977
97. Finfer S, Chittock DR, Su SY, Blair D, Foster D, Dhingra V, Bellomo R, Cook D, Dodek P, Henderson WR, Hébert PC, Heritier S, Heyland DK, McArthur C, McDonald E, Mitchell I, Myburgh JA, Norton R, Potter J, Robinson BG, Ronco JJ 2009 Intensive versus conventional glucose control in critically ill patients. N Engl J Med 360:1283-1297
98. Kansagara D, Fu R, Freeman M, Wolf F, Helfand M 2011 Intensive insulin therapy in hospitalized patients: a systematic review. Ann Intern Med 154:268-282
99. Engel-Nitz NM, Martin S, Sun P, Buesching D, Fonseca V 2008 Cardiovascular events and insulin therapy: a retrospective cohort analysis. Diabetes Res Clin Pract 81:97-104
100. Skyler, JS, Bergenstal R, Bonow RO, Buse J, Deedwania P, Gale EAM, Howard BV, Kirkman MS, Kosiborod M, Reaven P, Sherwin RS 2009 Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA Diabetes Trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association. Circulation 119:351-357
101. Gerstein HC, Miller ME, Byington RP, Goff Jr DC, Bigger JT, Buse JB, Cushman WC, Genuth S, Ismail-Beigi F, Grimm Jr RH, Probstfield JL, Simons-Morton DG, Friedewald WT 2008 Action to Control Cardiovascular Risk in Diabetes Study Group. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 358:2545-2559
102. Kelly TN, Bazzano LA, Fonseca VA, Thethi TK, Reynolds K, He J 2009 Systematic review: glucose control and cardiovascular disease in type 2 diabetes. Ann Intern Med 151:394-403
103. Riddle MC, Ambrosius WT, Brillon DJ, Buse JB, Byington RP, Cohen RM, Goff Jr DC, Malozowski S, Margolis KL, Probstfield JL, Schnall A, Seaquist ER 2010 Action to Control Cardiovascular Risk in Diabetes (ACCORD) Investigators. Epidemiologic relationships between A1C and all-cause mortality during a median 3.4-year follow-up of glycaemic treatment in the ACCORD trial. Diabetes Care 33:983-990
104. Natarajan SK, Dandona P, Karmon Y, Yoo AJ, Kalia JS, Hao Q, Hsu DP, Hopkins LN, Fiorella DJ, Bendok BR, Nguyen TN, Rymer MM, Nanda A, Liebeskind DS, Zaidat OO, Nogueira RG, Siddiqui AH, Levy EI 2011 Prediction of adverse outcomes by blood glucose level after endovascular therapy for acute ischemic stroke. J Neurosurg 114:1785-1799
105. Garg R, Chaudhuri A, Munschauer F, Dandona P 2006 Hyperglycemia, insulin, and acute ischemic stroke: a mechanistic justification for a trial of insulin infusion therapy. Stroke 37:267-273 (Pubitemid 43732090)
106. Zoungas S, Patel A, Chalmers J, de Galan BE, Li Q, Billot L, Woodward M, Ninomiya T, Neal B, MacMahon S, Grobbee DE, Kengne AP, Marre M, Heller S 2010 Severe hypoglycemia and risks of vascular events and death. N Engl J Med 363:1410-1418
107. Desouza CV, Bolli GB, Fonseca V 2010 Hypoglycemia, diabetes, and cardiovascular events. Diabetes Care 33:1389-1394
108. Kosiborod M, Inzucchi SE, Goyal A, Krumholz HM, Masoudi FA, Xiao L, Spertus JA 2009 Relationship between spontaneous and iatrogenic hypoglycemia and mortality in patients hospitalized with acute myocardial infarction. JAMA 301:1556-1564